<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>148(1)</volume><submitter>Chen MM</submitter><pubmed_abstract>&lt;h4>Importance&lt;/h4>Surveillance imaging and visits are costly and have not been shown to improve oncologic outcomes for patients with head and neck cancer (HNC). However, the benefit of surveillance visits may extend beyond recurrence detection. To better understand surveillance and potentially develop protocols to tailor current surveillance paradigms, it is important to elicit the perspectives of the clinicians who care for patients with HNC.&lt;h4>Objective&lt;/h4>To characterize current surveillance practices and explore clinician attitudes and beliefs on deintensifying surveillance for patients with HNC.&lt;h4>Design, setting, and participants&lt;/h4>This qualitative study was performed from January to March 2021. Guided by an interpretive description approach, interviews were analyzed to produce</pubmed_abstract><journal>JAMA otolaryngology-- head &amp; neck surgery</journal><pagination>43-51</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8569597</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance.</pubmed_title><pmcid>PMC8569597</pmcid><pubmed_authors>Pitt SC</pubmed_authors><pubmed_authors>Graboyes EM</pubmed_authors><pubmed_authors>Malloy KM</pubmed_authors><pubmed_authors>Miller J</pubmed_authors><pubmed_authors>Divi V</pubmed_authors><pubmed_authors>Dossett LA</pubmed_authors><pubmed_authors>Chen MM</pubmed_authors><pubmed_authors>Kazemi R</pubmed_authors><pubmed_authors>Mott NM</pubmed_authors><pubmed_authors>Stover M</pubmed_authors><pubmed_authors>Wallner LP</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinician Attitudes and Beliefs About Deintensifying Head and Neck Cancer Surveillance.</name><description>&lt;h4>Importance&lt;/h4>Surveillance imaging and visits are costly and have not been shown to improve oncologic outcomes for patients with head and neck cancer (HNC). However, the benefit of surveillance visits may extend beyond recurrence detection. To better understand surveillance and potentially develop protocols to tailor current surveillance paradigms, it is important to elicit the perspectives of the clinicians who care for patients with HNC.&lt;h4>Objective&lt;/h4>To characterize current surveillance practices and explore clinician attitudes and beliefs on deintensifying surveillance for patients with HNC.&lt;h4>Design, setting, and participants&lt;/h4>This qualitative study was performed from January to March 2021. Guided by an interpretive description approach, interviews were analyzed to produce</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jan</publication><modification>2025-04-26T20:48:26.167Z</modification><creation>2025-04-06T16:32:58.62Z</creation></dates><accession>S-EPMC8569597</accession><cross_references><pubmed>34734995</pubmed><doi>10.1001/jamaoto.2021.2824</doi></cross_references></HashMap>